Individualized intensified antiplatelet therapy based on platelet reactivity testing reduces the incidence of cardiovascular events in patients undergoing percutaneous coronary intervention

Anatol J Cardiol. 2017 Nov;18(5):376-377. doi: 10.14744/AnatolJCardiol.2017.8009.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Blood Platelets
  • Humans
  • Incidence
  • Percutaneous Coronary Intervention*
  • Platelet Aggregation Inhibitors*

Substances

  • Platelet Aggregation Inhibitors